A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/129
A61K 39/00 (2006.01)
Patent
CA 2011896
A ringworm vaccine is disclosed comprising antigen isolated from at least one dermatophyte and a suitable carrier. The "antigen" can include a single antigen from a dermatophyte or a plurality of antigens as long as at least one antigen is included which will produce a sufficient immune response to confer resistance to ringworm infection upon the recipient of the vaccine. The antigen can also be isolated from more than one dermatophyte. If a preparation from more than one dermatophyte is made the antigen can include antigens which are common to all species of dermatophytes employed and/or antigens which are only specific to certain species. A method of producing such a ringworm vaccine is also disclosed. The method comprises making an antigen preparation comprising the dermatophyte antigen described above and combining the antigen preparation with a suitable carrier. Methods of treating a patient are also disclosed employing the vaccine of the present invention and vaccines produced according to the method of the present invention. Methods are also disclosed for treating a pregnant patient with such vaccines such that the progeny of the pregnancy exhibit resistance to the ringworm infection at birth.
Strobel Michael
Werner Mark
Jefferson Labs Inc.
Riches Mckenzie & Herbert Llp
LandOfFree
Ringworm vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ringworm vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ringworm vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1448799